Search clinical trials for: Intermediate-1 Risk MDS

Total 62494 results

Fondazione Italiana Sindromi Mielodisplastiche-ETS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Terminated

Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts

Myelodysplastic Syndromes

Italy
M.D. Anderson Cancer Center
MDS Clinical Research Consortium

Completed

Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease

Leukemia

United States
Geron Corporation

Active, not recruiting

Study to Evaluate Imetelstat (GRN163L) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndromes

United States, Canada, Belgium, Spain, Czechia, Korea, Republic of, United Kingdom, Netherlands, Israel, Germany, Russian Federation, Switzerland, Italy, France, Turkey, Poland, Ukraine
University of Sao Paulo

Completed

Visual Performance of New Apodized Diffractive Multifocal IOL With Addition of Plus Three

To Study the Influence of an Multifocal Intraocular Lens With Different Addition on Intermediate Visual Acuity

Brazil
Massachusetts General Hospital
National Cancer Institute (NCI); Mayo Clinic; University of Pennsylvania; Washington... and other collaborators

Active, not recruiting

Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer (PARTIQoL)

Prostate Cancer

United States
Shi Ming

Withdrawn

Lenvatinib Plus PD-1 Antibody for Intermediate-stage HCC Beyond Up-to-seven Criteria

Hepatocellular Carcinoma

China
The First Affiliated Hospital of University of...

Recruiting

A Prospective Clinical Study Using an Artery-first Intermediate Approach in Robot-assisted Pancreaticoduodenectomy

Pancreatic Cancer | Common Bile Duct Diseases | Periampullary Carcinoma

China
Lawson Health Research Institute

Recruiting

PSMA MRI Guided Prostate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER) (ARGOS/CLIMBER)

Prostate Cancer

Canada
Danish Gynecological Cancer Group
European Organisation for Research and Treatment of Cancer - EORTC; Belgian... and other collaborators

Active, not recruiting

Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer

Endometrial Cancer

Denmark
University of Iowa

Completed

Covid-19 Associated Coagulopathy

COVID 19 Associated Coagulopathy

United States
Carsten Heinz

Completed

Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A

Uveitis

Germany
Gesellschaft fur Medizinische Innovation - Hamatologie...
Amgen

Completed

Validation of a Predictive Model of Response to Romiplostim in Patients With IPSS Low or Intermediate-1 Risk MDS and Thrombocytopenia (EUROPE)

Myelodysplastic Syndromes

France, Germany
Tianjin Medical University Cancer Institute and...

Recruiting

Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients

Breast Cancer

China
University of Liege

Unknown

Light Therapy in Disorders of Consciousness: Behavioral, Neuroimaging and (Neuro)Physiological Assessments.

Disorder of Consciousness
Ningbo No. 1 Hospital

Completed

MAFLD-simplified Definition as an Optimized Risk Stratification Tool for Predicting Metabolic Outcomes

Metabolic Associated Fatty Liver Disease
Ningbo No. 1 Hospital

Completed

Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver Disease

Nonalcoholic Fatty Liver Disease | Type2 Diabetes Mellitus | Light-to-moderate Alcohol Consumption

China
University Hospital Inselspital, Berne
University of Bern

Completed

Virtual Reality on the IMC

Feasibility of Virtual Reality Stimulation for Critically Ill Patients

Switzerland
Telik

Completed

Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...
Netherlands Organisation for Scientific Research; Aspen Pharma; CHU of Saint... and other collaborators

Completed

Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy (Highlow)

Pulmonary Embolism | Deep Venous Thrombosis

Norway, Netherlands, Denmark, France, Belgium, Ireland, United States, Canada, Russian Federation, Spain
Ryvu Therapeutics SA

Not yet recruiting

RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis (POTAMI-61)

Myelofibrosis

Italy, Poland
Janssen Research & Development, LLC
Janssen Research & Development, LLC

Active, not recruiting

Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

X-Linked Retinitis Pigmentosa

United States, Canada, Israel, United Kingdom, Spain, Denmark, France, Belgium, Italy, Netherlands, Switzerland
EyePoint Pharmaceuticals, Inc.

Terminated

Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert (FAI)

Uveitis | Uveitis, Posterior | Uveitis, Intermediate

United States
Ohio State University Comprehensive Cancer Center

Completed

Feasibility Study of a 60 Minute Rapid Infusion Rituximab Protocol in Patients With B-cell Malignancies

Indolent or Intermediate Grade B-cell Malignancy

United States
Forsight Vision4

Terminated

Safety and Preliminary Efficacy Study of V404 PDS in Uveitis

Uveitis, Posterior | Uveitis, Intermediate

United States
Hasan Kalyoncu University

Recruiting

Study of the Effect of Compassion-Based Education Program Applied to Mothers of Children Diagnosed With Cerebral Palsy

Cerebral Palsy

Turkey
Centre Hospitalier Universitaire Vaudois
GlaxoSmithKline; University Hospital, Geneva

Completed

Study of the Efficacy of Preoperative Cefuroxime Prophylaxis to Prevent Surgical Site Infection in Herniated Disk Surgery

Surgical Wound Infection

Switzerland
University Hospital, Caen
Centre Francois Baclesse

Unknown

Effect of Cervical Block on Recurrent Laryngeal Nerve Monitoring During Thyroid Surgery (THYRODOUL2)

Thyroid Surgery

France
Montefiore Medical Center
Albert Einstein College of Medicine

Withdrawn

Pyrimethamine for Intermediate/High-risk Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes

United States
Suleyman Demirel University

Recruiting

Developing a New Scale for Evaluating Shoulder Problems

Shoulder Injuries | Shoulder Pain | Shoulder Lesions

Turkey
University Health Network, Toronto
Medical College of Wisconsin Cancer Center, Allegheny Health Network, Austin...

Recruiting

MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach (MAESTRO)

Anal Squamous Cell Carcinoma

Canada, Australia, United States
Niguarda Hospital

Recruiting

Ischemic And Bleeding Risk Assessment After TAVR (FOCUS ONE)

Aortic Valve Stenosis | Transcatheter Aortic Valve Replacement

Italy, Belgium, Czechia, Chile, Spain
Onconova Therapeutics, Inc.

Completed

Efficacy and Safety of ON 01910.Na in Myelodysplastic Syndrome (MDS) Patients With Trisomy 8 or Classified as Intermediate-1, -2 or High Risk

Myelodysplastic Syndrome

United States
EZUS-LYON 1

Active, not recruiting

CARdioprotection in Myocardial Infarction (CARIM)

Myocardial Infarct

France
EZUS-LYON 1

Active, not recruiting

The Influence of Manual Therapy Applied to the Cervical Spine in the Prevention of Balance Disorders in the Elderly (ManEq)

Elderly | Gait | Balance, Postural

France
Priovant Therapeutics, Inc.

Not yet recruiting

A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis (CLARITY) (CLARITY)

Uveitis | Uveitis, Posterior | Uveitis, Intermediate
STZ eyetrial
Novartis Pharmaceuticals; University Hospital Tuebingen

Completed

Myfortic for the Treatment of Non-infectious Intermediate Uveitis (MYCUV-IIT02)

Uveitis, Intermediate

Germany
Stealth BioTherapeutics Inc.

Completed

Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy (MMPOWER)

Mitochondrial Myopathy

United States
University Medical Center Groningen

Completed

Walking the Isobole of Drug Interaction (Walibi)

Anesthesia | Hemodynamic Instability | Interaction | Disorder of Oxygen Transport

Netherlands
Azienda U.S.L. 1 di Massa e Carrara

Withdrawn

Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism (MONALYSE)

Pulmonary Embolism
Instituto de Investigacion Sanitaria La Fe

Completed

European Low and Intermediate Risk Neuroblastoma Protocol

LOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSES

Spain, Italy, Belgium, Denmark, Sweden, Norway, Israel, Switzerland, Australia, Austria
KBio Inc

Completed

Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults

Influenza

United States
Tampa Bay Uveitis Center, LLC
Mallinckrodt

Completed

Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients

Uveitis | Posterior Uveitis | Intermediate Uveitis | Anterior Uveitis | Scleritis | Clinically Significant Macular Edema

United States
Proton Collaborative Group

Recruiting

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

Prostate Cancer

United States
Lawson Health Research Institute
AbbVie; Canadian Association of Radiation Oncology

Active, not recruiting

Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer (HOPE)

Prostate Cancer

Canada
Azienda Ospedaliero-Universitaria Consorziale Policlinico...

Completed

Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer

Non Muscle Invasive Bladder Cancer
Centre Francois Baclesse

Terminated

Feasibility Study of a Dose Increase by a Boost of Curietherapy in Pulse Dose Rate (PDR) Associated With the Extern Radiotherapy in Prostate Cancer (CURIEBOOST)

Prostate Cancer With Intermediate Risk

France
Duke University

Completed

Use of ARINA-1 in an Intermediate Size Patient Population of Bilateral Lung Transplant Patients With CLAD Grade 0 (ARINA-1)

Lung Transplant

United States
Clearside Biomedical, Inc.

Completed

Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis

Panuveitis | Uveitis | Posterior Uveitis | Intermediate Uveitis | Noninfectious Uveitis

United States
Ningbo No. 1 Hospital

Completed

Nonalcoholic Fatty Liver Disease is Associated With Increased Atrial Fibrillation Risk in an Elderly Chinese Population

Atrial Fibrillation | Nonalcoholic Fatty Liver Disease | Cross-sectional Study

China
Cumhuriyet University
Aksaray University

Recruiting

The Effect of Education Based on Health Belief Model on Smoking Behaviors of Visually Impaired Individuals

Smoking | Health Risk Behaviors | Blind Eye

Turkey

Search clinical trials for: Intermediate-1 Risk MDS

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations